BioCentury
ARTICLE | Clinical News

Eptacog beta regulatory update

January 13, 2017 8:51 PM UTC

FDA accepted for review a BLA from LFB for eptacog beta to treat congenital hemophilia A or B in adolescents and adult congenital hemophilia A or B patients with inhibitors. HEMA Biologics LLC (Louisv...

BCIQ Company Profiles

LFB S.A.

US WorldMeds LLC